Cochrane Evidence Synthesis and Methods ►

Macrolides for the prevention of bronchopulmonary dysplasia in preterm neonates

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To determine if macrolide antibiotics are effective in the prevention of bronchopulmonary dysplasia in preterm neonates compared to no intervention.

To determine if one particular macrolide is more efficacious at preventing bronchopulmonary dysplasia in preterm neonates compared to other macrolides.

This is a protocol.

Published:

4 March 2022

Authors:

O’Connor KL, Davies MW

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
O’Connor KL, DaviesMW.Macrolides for the prevention of bronchopulmonary dysplasia in preterm neonates (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No.: CD015063. DOI: 10.1002/14651858.CD015063.